SFS
ALDX icon

Sowell Financial Services’s Aldeyra Therapeutics ALDX Stock Holding History

Sowell Financial Services’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$1K – 583
2021
Q1 		$1K Hold
100
– – ﹤0.01% 2892
2020
Q4 		$1K Hold
100
– – ﹤0.01% 2537
2020
Q3 		$1K Hold
100
– – ﹤0.01% 2314
2020
Q2 		$0 Buy
+100
New +$365 ﹤0.01% 2446

Other funds holding ALDX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Sowell Financial Services's ALDX Position: Q2 2021 in Review

Sowell Financial Services sold out of Aldeyra Therapeutics (ALDX) in Q2 2021, closing a stake of 100 shares — an estimated $1K sold.

Sowell Financial Services first reported a position in ALDX in Q2 2020 and held it in 4 quarters. The position peaked at $1K in Q1 2021. 136 funds tracked by Wall St. Rank hold ALDX as of Q2 2021.

  • Sowell Financial Services reported no remaining Aldeyra Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 100 Aldeyra Therapeutics shares in Q2 2021, an estimated $1K.
  • Sowell Financial Services first reported a position in Aldeyra Therapeutics in Q2 2020 and held it in 4 quarters.
  • Sowell Financial Services's Aldeyra Therapeutics position peaked at $1K in Q1 2021.
  • 136 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.